Successful technology transfer is essential for scaling gene therapy manufacturing processes from clinical to commercial stages. This poster highlights Viralgen’s proven methodology for ensuring a smooth and effective transfer, using a recent AAV comparability study as a case example. The poster details how a comprehensive gap analysis and risk assessment are employed to address potential challenges and ensure process consistency. By focusing on process performance and critical quality attributes, this approach helps ensure that therapeutic products maintain high standards of quality and safety as they transition through different production scales.
